Sigachi Industries Ltd. (Sigachi), India’s largest manufacturer of microcrystalline cellulose (MCC), has demonstrated robust financial performance in FY25 while setting the stage for aggressive future growth. With a strong EBITDA growth of 46.21 per cent YoY to Rs. 112 crore and a revenue surge of 25.42 per cent to Rs. 500.3 crore, Sigachi is positioning itself for a 25% CAGR through FY28, driven by capacity expansions, market diversification, and API development. 

Commenting on the company’s performance in FY25 and its projected trajectory, Mr. Amit Raj Sinha, MD & CEO, Sigachi Industries stated: "FY25 has been a transformative year for Sigachi, marked by robust financial outcomes and strategic expansions across excipients and APIs. With our Hyderabad API R&D centre going live in Q1 FY26, regulatory approvals flowing in, and global market penetration deepening, we are positioned for sustainable high-margin growth. Our 36-year legacy and diversified portfolio give us an unmatched advantage to scale operations globally while safeguarding profitability." 

Sigachi has created a strategic growth roadmap through to FY 2028 revolving around: 

API Expansion: With the integration of Trimax Biosciences, the company is scaling its advanced intermediate and API portfolio. Plans include filing six additional European CEP dossiers, expanding regulatory approvals, and ramping up capacity utilisation. 

Market Diversification: Sigachi is expanding its footprint beyond India, the U.S., and Europe by aggressively entering Latin America, Southeast Asia, and the Middle East through new distribution partnerships and turnkey O&M contracts. 

Excipient Capacity Growth: Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients. Additionally, new product launches in Pharma Coatings are expected to be the new growth drivers over the next two years.

Operational Efficiencies: Digital analytics, lean processing, and energy efficiency initiatives are expected to trim operating costs by 100-150 basis points annually, preserving EBITDA margins while mitigating raw-material volatility. 

O&M Services Expansion: The company is scaling its outsourced plant-management contracts, which already contribute 10% of revenues, with a particular focus on Middle East expansion.